{
  "scores": {
    "rubric_version": "v3.0-2025-10-14",
    "items": {
      "Title": {
        "score": 1,
        "evidence": "Ultrasonic Pupillometry for Nociception Monitoring: A Randomised Controlled Trial"
      },
      "Trial_Design": {
        "score": 2,
        "evidence": "randomised into three groups: group P (saline), group S1 (0.2 \u03bcg/kg sufentanil), and group S2 (0.4 \u03bcg/kg sufentanil). Randomisation was computer-generated with allocation concealment via sealed envelopes."
      },
      "Participants": {
        "score": 2,
        "evidence": "Ninety-three patients, aged 18-65 years, with ASA physical status I or II, scheduled for elective surgery under general anesthesia at the Second Affiliated Hospital of Soochow University"
      },
      "Intervention": {
        "score": 2,
        "evidence": "randomised into three groups: group P (saline), group S1 (0.2 \u03bcg/kg sufentanil), and group S2 (0.4 \u03bcg/kg sufentanil)."
      },
      "Objective": {
        "score": 1,
        "evidence": "This randomised controlled trial aimed to evaluate the correlation between ultrasonic pupillary dilation reflex (PDR) and sufentanil dose during anesthesia induction."
      },
      "Method_Outcome": {
        "score": 2,
        "evidence": "The primary outcome was PDR amplitude and rate, measured at four time points (T0-T3) using ultrasound."
      },
      "Randomisation_Allocation": {
        "score": 2,
        "evidence": "Randomisation was computer-generated with allocation concealment via sealed envelopes."
      },
      "Blinding": {
        "score": 2,
        "evidence": "Blinding was maintained for anesthesiologists and outcome assessors."
      },
      "Number_Randomised": {
        "score": 2,
        "evidence": "Ninety-three patients, aged 18-65 years, with ASA physical status I or II, scheduled for elective surgery under general anesthesia at the Second Affiliated Hospital of Soochow University, were enrolled from March 2021 to October 2023."
      },
      "Number_Analysed": {
        "score": 2,
        "evidence": "Of the 93 randomised, 89 were analysed (group P: 30, group S1: 31, group S2: 28)."
      },
      "Result_Outcome": {
        "score": 3,
        "evidence": "PDR amplitude and rate were negatively correlated with sufentanil dose [Spearman r = \u22120.84, 95% CI \u22120.88 to \u22120.77, p < 0.01; Spearman r = \u22120.74, 95% CI \u22120.82 to \u22120.64, p < 0.01]."
      },
      "Harms": {
        "score": 1,
        "evidence": "No adverse events were reported."
      },
      "Trial_Registration": {
        "score": 1,
        "evidence": "Trial registration: ChiCTR2100043771."
      },
      "Funding": {
        "score": 0,
        "evidence": "Funding: Not specified."
      }
    },
    "total_score": 23,
    "max_score": 25
  },
  "model": "gpt-4o"
}